Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation

被引:38
作者
Li, Ying [1 ,2 ,3 ]
Yang, Da-Jian [3 ]
Chen, Shi-Lin [3 ,4 ]
Chen, Si-Bao [3 ,4 ]
Chan, Albert Sun-Chi [3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China
[2] Shenzhen Virtual Univ Pk Postdoc Stn, Shenzhen, Peoples R China
[3] State Key Lab Chinese Med & Mol Pharmacol, Shenzhen, Peoples R China
[4] Chinese Acad Med Coll, Inst Med Plant Dev, Beijing, Peoples R China
关键词
puerarin; phospholipids complex; microparticles; supercritical fluids; SEDS; GAS;
D O I
10.1016/j.ijpharm.2008.03.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to develop and evaluate a new method for the production of puerarin phospholipids complex (PPC) microparticles. The advanced particle formation method, solution enhanced dispersion by supercritical fluids (SEDS), was used for the preparation of puerarin (Pur), phospholipids (PC) and their complex particles for the first time. Evaluation of the processing variables on PPC particle characteristics was also conducted. The processing variables included temperature, pressure, solution concentration, the flow rate of supercritical carbon dioxide (SC-CO2) and the relative flow rate of drug solution to CO2. The morphology, particle size and size distribution of the particles were determined. Meanwhile Pur and phospholipids were separately prepared by gas antisolvent precipitation (GAS) method and solid characterization of particles by the two supercritical methods was also compared. Pur formed by GAS was more orderly, purer crystal, whereas amorphous Put particles between 0.5 and 1 mu m were formed by SEDS. The complex was successfully obtained by SEDS exhibiting amorphous, partially agglomerated spheres comprised of particles sized only about 1 mu m. SEDS method may be useful for the processing of other pharmaceutical preparations besides phospholipids complex particles. Furthermore adopting a GAS process to recrystallize pharmaceuticals will provide a highly versatile methodology to generate new polymorphs of drugs in addition to conventional techniques. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 34 条
[1]  
Badens E, 2001, BIOTECHNOL BIOENG, V72, P194, DOI 10.1002/1097-0290(20000120)72:2<194::AID-BIT8>3.0.CO
[2]  
2-L
[3]   Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery [J].
Bakhbakhi, Y ;
Charpentier, PA ;
Rohani, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 309 (1-2) :71-80
[4]   Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin [J].
Charoenchaitrakool, M ;
Dehghani, F ;
Foster, NR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :103-112
[5]  
CHEN DY, 2002, BEIJING DAILY CHEM, V66, P15
[6]   Comparative physicochemical properties of hydrocortisone-PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying [J].
Corrigan, OI ;
Crean, AM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) :75-82
[7]   POLYMERIC MATERIALS FORMED BY PRECIPITATION WITH A COMPRESSED FLUID ANTISOLVENT [J].
DIXON, DJ ;
JOHNSTON, KP ;
BODMEIER, RA .
AICHE JOURNAL, 1993, 39 (01) :127-139
[8]   Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs [J].
Duarte, ARC ;
Costa, MS ;
Simplício, AL ;
Cardoso, MM ;
Duarte, CMM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 308 (1-2) :168-174
[9]   Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques [J].
Elvassore, N ;
Bertucco, A ;
Caliceti, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (10) :1628-1636
[10]   Production of different morphologies of biocompatible polymeric materials by supercritical CO2 antisolvent techniques [J].
Elvassore, N ;
Baggio, M ;
Pallado, P ;
Bertucco, A .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 73 (06) :449-457